canakinumab
novartis
['canakinumab']
canakinumab provides a significant reduction in disease severity, attack frequency, and acute phase reactant levels in fmf. abs 1834 #acr22 
Passionately curious rheumatologist, world traveler, wife, mother, sister, daughter, friend, dog lover. Believer in scientific method & evidence based medicine.